Arcadia Life Sciences - About the company
Arcadia Life Sciences is an unfunded company based in Kuala Lumpur (Malaysia), founded in 2019. It operates as a Provider of biomarker discovery, translation, and healthcare application development solutions. Arcadia Life Sciences has not raised any funding yet. The company has 159 active competitors, including 18 funded and 24 that have exited. Its top competitors include companies like Owkin, Novotech and Dotmatics.
Company Details
Provider of biomarker discovery, translation, and healthcare application development solutions. The company offers integrated ecosystem solutions for clinically and commercially viable healthcare applications. It focuses on biospecimen and data management, clinical laboratory services, and newborn screening. The company also provides clinical operations and patient affairs support.
- Website
- arcadialifesciences.com
- Social
- Email ID
- *****@arcadialifesciences.com
Key Metrics
Sign up to download Arcadia Life Sciences' company profile
Arcadia Life Sciences's funding and investors
Arcadia Life Sciences has not raised any funding rounds yet.
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Arcadia Life Sciences's Competitors and alternates
Top competitors of Arcadia Life Sciences include Owkin, Novotech and Dotmatics. Here is the list of Top 10 competitors of Arcadia Life Sciences, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Developer of agentic AI platform for biomedical research and drug development | $354M | 71/100 | ||
2nd | Provider of clinical research services across all trial phases and therapeutic areas | $255M | 68/100 | ||
3rd | Dotmatics 2005, Bishop s Stortford (United Kingdom), Acquired | AI powered scientific data management and workflow automation solutions | $11.3M | 64/100 | |
4th |  Concert AI 2018, Boston (United States), Series C | Provider of AI and real-world data solutions for life sciences | $300M | 63/100 | |
5th | Developer of AI foundation model to transform biological research | $76M | 62/100 | ||
6th | Digital Science 2010, London (United Kingdom), Funding Raised | Research assistance software solutions | - | 60/100 | |
7th | Doctor Evidence 2004, Santa Monica (United States), Acquired | Evidence based medical decision solutions for multiple healthcare stakeholders | $1.5M | 56/100 | |
8th | Sygnature Discovery 2004, Nottingham (United Kingdom), Series A | Provider of services and products for integrated drug discovery | - | 56/100 | |
9th | Instem 1969, Conshohocken (United States), Acquired | Software solutions for data collection, management, and analysis for the life science industry | - | 55/100 | |
10th | _1560500852706.png?devicePixelRatio=2&height=30&width=30){kind=logo} Intelligencia 2018, New York City (United States), Series A | Cloud and AI-led analytics platform for drug discovery and development | $13.8M | 52/100 | |
169th |  Arcadia Life Sciences 2019, Kuala Lumpur (Malaysia), Unfunded | Provider of biomarker discovery, translation, and healthcare application development solutions | - | - | 16/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Arcadia Life Sciences's competitors? Click here to see the top ones
Arcadia Life Sciences's Investments and acquisitions
Arcadia Life Sciences has made no investments or acquisitions yet.
Are you a Founder ?
FAQs about Arcadia Life Sciences
Explore our recently published companies
